Perrigo announced that the Food and Drug Administration (FDA) has granted final approval for Guaifenesin and Dextromethorphan Hydrobromide Extended-Release Tablets, 1200mg/60mg, the generic version of Reckitt Benckiser‘s Mucinex DM Maximum Strength.
Mucinex DM Maximum Strength is indicated to manage coughs and break up mucus, making coughs more productive. The extended-release bi-layer tablets contain dextromethorphan HBr, an antitussive, and guaifenesin, an expectorant.
Perrigo plans to make Guaifenesin and Dextromethorphan Hydrobromide Extended-Release Tablets available in time for the 2018 cough and cold season.
For more information visit Perrigo.com.